Tower Research Capital (TRC)’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$128K Buy
13,850
+9,463
+216% +$87.2K ﹤0.01% 2176
2025
Q1
$37.9K Buy
4,387
+1,004
+30% +$8.67K ﹤0.01% 2432
2024
Q4
$36.3K Buy
3,383
+1,708
+102% +$18.3K ﹤0.01% 2766
2024
Q3
$9.51K Sell
1,675
-21,996
-93% -$125K ﹤0.01% 3860
2024
Q2
$99.9K Buy
23,671
+22,926
+3,077% +$96.7K ﹤0.01% 2580
2024
Q1
$3.79K Sell
745
-9,892
-93% -$50.4K ﹤0.01% 4793
2023
Q4
$99K Buy
10,637
+2,594
+32% +$24.2K ﹤0.01% 2647
2023
Q3
$52.7K Buy
8,043
+2,594
+48% +$17K ﹤0.01% 2507
2023
Q2
$44.3K Buy
5,449
+1,348
+33% +$11K ﹤0.01% 2655
2023
Q1
$35K Sell
4,101
-1,233
-23% -$10.5K ﹤0.01% 2832
2022
Q4
$49K Sell
5,334
-2,598
-33% -$23.9K ﹤0.01% 2359
2022
Q3
$82K Sell
7,932
-2,371
-23% -$24.5K ﹤0.01% 2727
2022
Q2
$103K Buy
10,303
+5,140
+100% +$51.4K ﹤0.01% 2261
2022
Q1
$63K Sell
5,163
-6,262
-55% -$76.4K ﹤0.01% 2544
2021
Q4
$198K Sell
11,425
-712
-6% -$12.3K ﹤0.01% 1777
2021
Q3
$218K Buy
12,137
+4,230
+53% +$76K 0.01% 1736
2021
Q2
$181K Sell
7,907
-12,278
-61% -$281K ﹤0.01% 2002
2021
Q1
$301K Buy
20,185
+9,651
+92% +$144K 0.01% 1663
2020
Q4
$57K Sell
10,534
-46,363
-81% -$251K ﹤0.01% 2966
2020
Q3
$259K Buy
56,897
+46,566
+451% +$212K ﹤0.01% 2315
2020
Q2
$51K Buy
+10,331
New +$51K ﹤0.01% 3026
2019
Q4
Sell
-689
Closed -$2K 3519
2019
Q3
$2K Sell
689
-5,954
-90% -$17.3K ﹤0.01% 3653
2019
Q2
$22K Buy
6,643
+3,313
+99% +$11K ﹤0.01% 2111
2019
Q1
$10K Sell
3,330
-13,242
-80% -$39.8K ﹤0.01% 2662
2018
Q4
$26K Buy
16,572
+3,205
+24% +$5.03K ﹤0.01% 1729
2018
Q3
$36K Buy
13,367
+473
+4% +$1.27K ﹤0.01% 1957
2018
Q2
$34K Buy
+12,894
New +$34K ﹤0.01% 2088
2018
Q1
Sell
-5,609
Closed -$18K 3243
2017
Q4
$18K Sell
5,609
-12,259
-69% -$39.3K ﹤0.01% 2140
2017
Q3
$74K Buy
+17,868
New +$74K 0.01% 1622
2017
Q1
Sell
-5,049
Closed -$20K 3044
2016
Q4
$20K Buy
+5,049
New +$20K ﹤0.01% 2126
2016
Q3
Sell
-891
Closed -$5K 3614
2016
Q2
$5K Sell
891
-10,003
-92% -$56.1K ﹤0.01% 3345
2016
Q1
$53K Buy
10,894
+10,003
+1,123% +$48.7K 0.01% 749
2015
Q4
$5K Buy
+891
New +$5K ﹤0.01% 2931